Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025)

Drugs Made In America Acquisition's (DMIIR) quarterly Change in Account Payables came in at $94767.0 in Q4 2025.

Drugs Made In America Acquisition (DMIIR) Change in Account Payables (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has 1 years of Change in Account Payables data on file, last reported at $94767.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 EQV Ventures Acquisition 480.75 Mn 480.75 Mn - -
2 Agriculture & Natural Solutions Acquisition 393.29 Mn 393.29 Mn - -6.67 Mn
3 Berto Acquisition 314.56 Mn 314.35 Mn - -1,876.00
4 GP-Act III Acquisition 313.66 Mn 313.66 Mn - -
5 Centurion Acquisition 311.65 Mn 311.65 Mn - -
6 Republic Digital Acquisition 310.50 Mn 309.63 Mn - -
7 Siddhi Acquisition Corp (Cayman Islands) 288.97 Mn 288.97 Mn - -
8 K&F Growth Acquisition 283.42 Mn 283.42 Mn - -
9 Bold Eagle Acquisition 275.29 Mn 275.29 Mn - 4,745.00
10 Drugs Made In America Acquisition - - - 94,767.00

Historic Data

Download Data
DateValue
Dec 31, 2025 94,767.00
Dec 31, 2025 94,767.00